2Doll R,Hill AB. Smoking and Carcinoma of the Lung; preliminary report. Br Med J,1950,2:739-748.
3Wakelee HA, Chang ET, Gomez SL,et al. Lung cancer incidence in never smokers. J Clin Oncol,2007,25:472-478.
4Sardari Nia P, Weyler J, Colpaert C, et al. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer, 2005,47 : 351-359.
5Shriver SP, Bourdeau HA, Gubish CT, et al. Sex-specific expression of gastrin-realing peptide receptor-relationship to smoking history and risk of lung cancer. J Natl Cancer Inst,2000,92:24-33.
6Van Rens MT, de la Riviere AB, Elbers HR, et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, Stage Ⅰ, Ⅱ, and ⅢA. Chest,2000,117 : 374 -379.
7Thatcher N, Chang A, Parikh P, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomized, placebo-controlled, muhicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet ,2005,366 : 1527 -1537.
8Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med,2005, 353:123-132.
